New hope for high-risk research?
Lancet Oncol
.
2003 Nov;4(11):648.
doi: 10.1016/s1470-2045(03)01259-2.
Author
Mary Weideman
PMID:
14621684
DOI:
10.1016/s1470-2045(03)01259-2
No abstract available
Publication types
News
MeSH terms
Clinical Trials as Topic / trends*
Humans
National Institutes of Health (U.S.)
Neoplasms / therapy*
Research / trends*
United States